An 11-year-old Hong Kong girl vaccinated with the Pfizer-BioNTech vaccine had symptoms of myocarditis.
Since then, the Hong Kong Centre for Health Protection extended the interval between the first and second doses of the Pfizer-BioNTech vaccine from three to eight weeks for people between 18 and 59.